Varex Imaging (VREX) Aandelenoverzicht
Varex Imaging Corporation ontwerpt, produceert en verkoopt röntgenbeeldvormingscomponenten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 0/6 |
VREX Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Varex Imaging Corporation Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$10.37 |
| 52 Week Hoogtepunt | US$14.57 |
| 52 Week Laag | US$6.76 |
| Bèta | 0.90 |
| 1 maand verandering | 2.98% |
| 3 maanden verandering | -3.80% |
| 1 Jaar Verandering | 27.55% |
| 3 jaar verandering | -54.48% |
| 5 jaar verandering | -61.33% |
| Verandering sinds IPO | -61.97% |
Recent nieuws en updates
Narratiefupdate • Jun 17
VREX: Higher Long Term P/E Assumption Will Drive Future Repricing
The analyst price target for Varex Imaging has moved slightly lower to $18.0 from $18.4, with analysts citing updates in discount rate, revenue growth, profit margin and future P/E assumptions as key drivers of the change. What’s in the News for Varex Imaging Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenues in the range of $210 million to $225 million.
Narratiefupdate • Jun 02
VREX: Future Upside Will Rely On Executing 2026 Revenue Guidance
Analysts have kept their $16.00 price target for Varex Imaging unchanged, citing updated assumptions that now reflect a slightly lower discount rate, a modest adjustment to expected revenue growth and profit margins, and a higher future P/E multiple. What's in the News Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenue in the range of $210 million to $225 million.Narratiefupdate • May 12
VREX: Future Upside Will Depend On Discount Rate And Margin Delivery
Analysts have raised their price target on Varex Imaging from $16.00 to $18.00, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. Analyst Commentary Even with the price target moving to US$18.00, some bearish analysts are stressing that this is not an all clear signal for Varex Imaging.Narratiefupdate • Apr 27
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.Recent updates
Narratiefupdate • Jun 17
VREX: Higher Long Term P/E Assumption Will Drive Future Repricing
The analyst price target for Varex Imaging has moved slightly lower to $18.0 from $18.4, with analysts citing updates in discount rate, revenue growth, profit margin and future P/E assumptions as key drivers of the change. What’s in the News for Varex Imaging Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenues in the range of $210 million to $225 million.Narratiefupdate • Jun 02
VREX: Future Upside Will Rely On Executing 2026 Revenue Guidance
Analysts have kept their $16.00 price target for Varex Imaging unchanged, citing updated assumptions that now reflect a slightly lower discount rate, a modest adjustment to expected revenue growth and profit margins, and a higher future P/E multiple. What's in the News Varex Imaging issued earnings guidance for the third quarter of fiscal 2026, with expected revenue in the range of $210 million to $225 million.Narratiefupdate • May 12
VREX: Future Upside Will Depend On Discount Rate And Margin Delivery
Analysts have raised their price target on Varex Imaging from $16.00 to $18.00, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E levels. Analyst Commentary Even with the price target moving to US$18.00, some bearish analysts are stressing that this is not an all clear signal for Varex Imaging.Narratiefupdate • Apr 27
VREX: Future Upside Will Depend On Q2 2026 Revenue And Margin Delivery
Analysts recently raised their price target on Varex Imaging by $2. This change reflects updated views on revenue growth, profit margin potential, and a lower assumed future P/E multiple, while keeping fair value estimates unchanged.Narratiefupdate • Apr 10
VREX: Refined Discount Rate And P/E Assumptions Will Support Future Repricing
Analysts recently raised their price target on Varex Imaging by $2, reflecting updated assumptions on discount rate, profit margin, and future P/E. They see these assumptions as better aligned with the company’s risk and earnings profile.Narratiefupdate • Mar 26
VREX: Higher Profitability Assumptions Will Support A Repriced Earnings Multiple
Analysts have raised their average price target for Varex Imaging by $1, reflecting updated views on fair value, profitability assumptions, and P/E expectations cited in recent research, including the latest move from B. Riley.Narratiefupdate • Mar 12
VREX: Future Returns Will Hinge On Executing Q2 2026 Revenue Guidance
Narrative Update on Varex Imaging Analysts have lifted their price target on Varex Imaging by $2, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that support a refreshed view of the company’s valuation profile. Analyst Commentary Even with the updated price target, some bearish analysts remain cautious.Narratiefupdate • Feb 25
VREX: Future Returns Will Depend On Delivering Q2 2026 Guidance Execution
Analysts have lifted their price target on Varex Imaging to $16.0 from $14.5, citing updated assumptions around fair value, discount rate, revenue, profit margin and future P/E following recent research that included a $2 increase in target price at B. Riley.Narratiefupdate • Feb 11
VREX: Future Returns Will Balance Q4 Beat Against Ongoing Execution Risks
Analysts have revised their fair value estimate for Varex Imaging to $14.50 from $12.00, citing updated assumptions on the discount rate, revenue growth, profit margins and future P/E. This follows recent research that included a lower Street price target of $18 from $23, after Q4 revenue of $229M came in above prior estimates and guidance.Analyseartikel • Feb 05
It Looks Like Varex Imaging Corporation's (NASDAQ:VREX) CEO May Expect Their Salary To Be Put Under The Microscope
Key Insights Varex Imaging to hold its Annual General Meeting on 12th of February Total pay for CEO Sunny Sanyal...Narratiefupdate • Jan 27
VREX: Future Returns Will Reflect Cautious Stance After Lowered Price Outlook
Narrative Update Analysts have trimmed their price target on Varex Imaging by $5 to $18, citing recent Q4 revenue of $229M coming in above their estimates and within guidance, along with Q1 2026 revenue guidance of $200M to $215M that aligns closely with current expectations. Analyst Commentary Bearish analysts are reacting to the recent update by trimming their expectations, even as the latest numbers line up with prior guidance and estimates.Narratiefupdate • Jan 10
VREX: Future Returns Will Reflect Trimmed Outlook After Q1 2026 Revenue Guidance
Narrative Update on Varex Imaging The analyst consensus price target for Varex Imaging has shifted to US$18 from US$23, with analysts pointing to the recent Q4 revenue outcome of US$229m versus prior expectations and the Q1 2026 guidance range of US$200m to US$215m as key inputs behind the revision. Analyst Commentary Bearish analysts have responded to the latest results and guidance by trimming their expectations, even though the recent Q4 revenue outcome of US$229m sat at the high end of management's US$210m to US$230m range and ahead of prior estimates.Analyseartikel • Jan 09
Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Narratiefupdate • Dec 14
VREX: Future Performance Will Reflect Trimmed Outlook Amid Solid Recent Results
Analysts have trimmed their price target on Varex Imaging to $18 from $23, citing slightly softer long term growth assumptions, despite recent quarterly revenues and forward guidance coming in ahead of or in line with prior expectations. Analyst Commentary Bearish analysts acknowledge Varex Imaging's better than expected quarterly performance and solid positioning within its end markets, but remain cautious on the durability of growth and the balance of risk and reward at current levels.Analyseartikel • Nov 20
Varex Imaging Corporation (NASDAQ:VREX) Shares Could Be 35% Below Their Intrinsic Value Estimate
Key Insights Varex Imaging's estimated fair value is US$15.84 based on 2 Stage Free Cash Flow to Equity Varex Imaging's...Analyseartikel • Aug 10
Varex Imaging Corporation (NASDAQ:VREX) Just Reported Earnings, And Analysts Cut Their Target Price
NasdaqGS:VREX 1 Year Share Price vs Fair Value Explore Varex Imaging's Fair Values from the Community and select yours...Analyseartikel • Aug 06
The Returns At Varex Imaging (NASDAQ:VREX) Aren't Growing
NasdaqGS:VREX 1 Year Share Price vs Fair Value Explore Varex Imaging's Fair Values from the Community and select yours...Analyseartikel • Jul 19
Calculating The Intrinsic Value Of Varex Imaging Corporation (NASDAQ:VREX)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Varex Imaging fair value estimate is US$8.72 With US$7.24...Analyseartikel • Jun 10
These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Extensively
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analyseartikel • May 11
Earnings Beat: Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Varex Imaging Corporation ( NASDAQ:VREX ) just released its quarterly report and things are looking bullish. The...Analyseartikel • Apr 25
Lacklustre Performance Is Driving Varex Imaging Corporation's (NASDAQ:VREX) 32% Price Drop
To the annoyance of some shareholders, Varex Imaging Corporation ( NASDAQ:VREX ) shares are down a considerable 32% in...Analyseartikel • Apr 25
Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Revenues As Shares Take 32% Pounding
To the annoyance of some shareholders, Varex Imaging Corporation ( NASDAQ:VREX ) shares are down a considerable 32% in...Analyseartikel • Apr 04
Be Wary Of Varex Imaging (NASDAQ:VREX) And Its Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Seeking Alpha • Jan 21
Varex Imaging Corporation: A Mixed Picture
Summary Varex Imaging Corporation's stock has declined 25% over the past year, and revenues decreased year-over-year basis in the most recent quarter. The stock did see net insider buying in its stock in 2024 and Varex did deliver solid operating cash flow in its last quarterly earnings report. What is ahead for Varex and its shareholders in 2025? An updated analysis of Varex Imaging Corporation follows in the paragraphs below. Read the full article on Seeking AlphaAnalyseartikel • Dec 19
Varex Imaging (NASDAQ:VREX) Is Finding It Tricky To Allocate Its Capital
If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When we...Analyseartikel • Nov 07
There's Reason For Concern Over Varex Imaging Corporation's (NASDAQ:VREX) Massive 29% Price Jump
The Varex Imaging Corporation ( NASDAQ:VREX ) share price has done very well over the last month, posting an excellent...Analyseartikel • Oct 22
Does Varex Imaging (NASDAQ:VREX) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Nieuw narratief • Sep 24
Expanding In India And Innovating In Photon Technology Boosts Prospects Despite Challenges In China And Semiconductor Softness
Expansion into India and focus on photon counting technology aim to recover market share in radiographic and dental sectors, potentially increasing revenue.Seeking Alpha • Sep 11
Varex Imaging: Headroom Capped Without Higher Earnings On Capital Employed
Summary Varex Imaging has high net working capital density and low capital turnover that see it earn sub-par rates on its operating assets. Varex's Q3 FY24 earnings showed extended weakness across all operating domains, with China a continued drag on performance. Valuations are unsupportive and without capacity to roll back cash earnings to grow the capital base or earnings power, my view is VREX is worth ~$13/share today. Read the full article on Seeking AlphaAnalyseartikel • Aug 20
Little Excitement Around Varex Imaging Corporation's (NASDAQ:VREX) Earnings
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 18x, you may...Analyseartikel • May 10
We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
Despite posting healthy earnings, Varex Imaging Corporation's ( NASDAQ:VREX ) stock has been quite weak. Along with the...Seeking Alpha • Feb 07
Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Summary Today, we look at Varex Imaging Corporation, which just posted Q1 2024 results, with non-GAAP earnings of six cents a share, falling short of expectations. The company is facing several near-term headwinds, but profit and sales growth are projected to return in FY2025. An analysis around Varex Imaging Corporation is presented in the paragraphs below. Read the full article on Seeking AlphaAnalyseartikel • Dec 14
We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Rendement voor aandeelhouders
| VREX | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | 1.7% | -1.7% | -2.3% |
| 1Y | 27.6% | -22.4% | 21.2% |
Rendement versus industrie: VREX overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement -22.4 % opleverde.
Rendement versus markt: VREX overtrof de US markt, die het afgelopen jaar een rendement opleverde van 21.2 %.
Prijsvolatiliteit
| VREX volatility | |
|---|---|
| VREX Average Weekly Movement | 8.0% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: VREX heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van VREX is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2016 | 2,450 | Sunny Sanyal | www.vareximaging.com |
Varex Imaging Corporation ontwerpt, produceert en verkoopt röntgenbeeldvormingscomponenten. Het bedrijf opereert via twee segmenten, medisch en industrieel. Het medische segment ontwerpt, produceert, verkoopt en onderhoudt röntgenbeeldvormingscomponenten, waaronder röntgenbuizen, digitale detectoren en accessoires, ionisatiekamers, hoogspanningsconnectoren, beeldverwerkingssoftware en werkstations, 3D-reconstructiesoftware, computerondersteunde diagnostische software, collimatoren, automatische belichtingsregelaars, generatoren en warmtewisselaars.
Varex Imaging Corporation Samenvatting
| VREX fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$443.38m |
| Inkomsten(TTM) | -US$82.70m |
| Inkomsten(TTM) | US$857.50m |
0.5x
P/S-verhouding-5.3x
Koers/WinstverhoudingIs VREX overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| VREX resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$857.50m |
| Kosten van inkomsten | US$569.80m |
| Brutowinst | US$287.70m |
| Overige uitgaven | US$370.40m |
| Inkomsten | -US$82.70m |
Laatst gerapporteerde inkomsten
Apr 03, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -1.96 |
| Brutomarge | 33.55% |
| Nettowinstmarge | -9.64% |
| Schuld/Eigen Vermogen Verhouding | 71.2% |
Hoe presteerde VREX op de lange termijn?
Bekijk historische prestaties en vergelijkingBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/06/24 21:52 |
| Aandelenkoers aan het einde van de dag | 2026/06/24 00:00 |
| Inkomsten | 2026/04/03 |
| Jaarlijkse inkomsten | 2025/10/03 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Varex Imaging Corporation wordt gevolgd door 9 analisten. 5 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Anderson Schock | B. Riley Securities, Inc. |
| Lawrence Solow | CJS Securities, Inc. |
| Rajbir Denhoy | Jefferies LLC |